NFKB1 and Insulin resistance: Targeted disruption of IKKβ in the liver would reverse diet-induced insulin resistance, while systemic insulin resistance results from hepatic overexpression of IKKβ and NF-κB (Yuan et al., 2001; Cai et al., 2005).